|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| C07D 471/04 | (2013.01) | ||
| C07D 491/04 | (2006.01) | ||
| C07D 491/04 | (2013.01) | ||
| Y02P 20/55 | (2015.11) |
| (11) | Number of the document | 3911651 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20702386.2 |
| Date of filing the European patent application | 2020-01-15 | |
| (97) | Date of publication of the European application | 2021-11-24 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2020/050312 |
| Date | 2020-01-15 |
| (87) | Number | WO 2020/148679 |
| Date | 2020-07-23 |
| (30) | Number | Date | Country code |
| 201962793462 P | 2019-01-17 | US |
| (72) |
HARSANYL, Antal , GB
SEARLE, Andrew David , GB
|
| (73) |
ViiV Healthcare UK (No.4) Limited ,
GSK Medicines Research Centre
Gunnels Wood Road, Stevenage SG1 2NY,
GB
|
| (54) | PROCESS FOR PREPARING FOSTEMSAVIR |
| PROCESS FOR PREPARING FOSTEMSAVIR |